An update from BioNTech SE ( ($BNTX) ) is now available. On January 6, 2026, BioNTech SE reported that CureVac N.V. had completed a previously ...

Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.

Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.

BioNTech SE (NASDAQ:BNTX) is one of the Stocks That Will Go To The Moon in 2026. On December 18, BioNTech SE (NASDAQ:BNTX) announced the closing of its acquisition of CureVac N.V. (NASDAQ:CVAC), which ...

The AI software company has standout margins and revenue growth, the combination of which helps justify a premium price for ...

Pfizer and BioNTech previously announced that their jointly developed COVID-19 vaccine showed over 90% effectiveness in preventing infection based on initial trial data, although scientists ...

The new corporate home to the cable channels CNBC, MS Now and USA Network has started off losing 25% of its market value ...

BitMine Immersion Technologies Inc. (NYSE:BMNR) shares rallied in Sunday overnight trading on Robinhood after Chair Tom Lee ...

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T ...

One Houston-based public company saw its stock price increase nearly 400% in 2025, while five others saw share prices grow ...

Shares in Rocket Lab Corp were heading for their second day of gains on Monday after the aerospace manufacturer was named as one of four companies that will build tracking satellites for the U.S.

It’s been a tumultuous year for U.S. stock markets. Investors have had their nerves rattled twice this year by government-related events—President Trump’s Liberation Day tariffs in the spring, ...